Clinical characteristics of patients
| No./Age (yr)/Sex | Location of Epilepsy | Age at Seizure Onset (yr) | Duration of Epilepsy (yr) | Antiepileptic Medications | Seizure Frequency/Week |
|---|---|---|---|---|---|
| 1/15.2/F | R frontal | 7 | 8 | Lamotrigine, levetiracetam | 7 |
| 2/16.3/F | R frontal paracentral | 14 | 2.3 | Carbamazepine | 7 |
| 3/10.0/F | R neocortical inferior temporal | 7 | 3 | Lamotrigine, topiramate | 10 |
| 4/15.3/F | R frontal paracentral | 3 | 12.3 | Carbamazepine, lamotrigine, divalproex | 10 |
| 5/14.0/M | L frontal | 8 | 6 | Valproic acid, lamotrigine | 20 |
| 6/10.1/F | L neocortical anterior temporal | 8 | 2 | Carbamazepine | 10 |
| 7/16.2/M | L frontal paracentral | 8 | 8 | Carbamazepine, levetiracetam | 10 |
| 8/14.1/M | L neocortical anterior temporal | 12 | 2 | Lamotrigine, levetiracetam | 2 |
| 9/14.7/F | R hemisphere | 13 | 1 | Levetiracetam, divalproex, valproic acid | 2.5 |
| 10/15.0/F | L frontal | 4.5 | 10.5 | Oxcarbazepine | 40 |
| 11/14.1/F | R lateral parietal occipital | 10 | 4 | Levetiracetam, topiramate | 40 |
Note:—R indicates right; L, left.